查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1621148

2024 - 2032 年動物藥品市場機會、成長動力、產業趨勢分析與預測

Animal Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年，全球動物藥品市場規模達370億美元，預計2024年至2032年複合年成長率為5.4%，到預測期結束時將超過450億美元。主要促進因素包括動物疾病盛行率上升、消費者對動物健康意識的提高以及擴大採用牲畜進行食品生產。獸藥配方的進步也促進了市場成長，確保更好的功效和合規性。

包括抗感染藥、殺寄生蟲藥和疫苗在內的藥品佔據市場主導地位，持續創新推動成長。 2023年，藥物領域在動物藥物市場中累積佔58.8%的最大佔有率，並且在新配方的引入和聯合療法的使用增加的幫助下，預計將顯著成長。人們對預防保健的認知不斷提高，以及牲畜和伴侶動物疫苗接種計劃的重要性，推動了對這些藥物的需求。此外，生物技術和分子研究的進步有助於開發高效治療方法。

到 2023 年，畜牧業佔據了約 62.5% 的主導佔有率。用於預防疾病爆發和最佳化動物生產力的預防性和治療性藥物的使用推動了該細分市場的成長。此外，全球生產者和政府對農場動物健康的投資不斷增加，預計將維持強勁的需求。

市場範圍
開始年份 2023年
預測年份 2024-2032
起始值 370 億美元
預測值 596 億美元
複合年成長率 5.4%

2023 年，注射藥物銷售額達 166 億美元，由於其起效快且易於劑量控制，作為首選給藥途徑越來越受到關注。它們通常用於伴侶動物和牲畜的疫苗接種、抗生素和激素治療。配方和輸送系統的創新提高了注射藥物的穩定性和有效性，使其成為獸醫實踐中的重要工具。該領域的成長得益於動物保健意識的提高和進步。

到 2023 年，獸醫醫院將佔據整體市場佔有率的 37.4%，並且在全面醫療服務和先進治療的推動下，預計將繼續保持領先的配銷通路。寵物擁有量的激增和對牲畜福利的日益關注進一步支持了細分市場的成長。這些醫院擁有熟練的獸醫和先進的診斷設施，確保了藥物的有效管理。綜合醫療保健系統的趨勢進一步加強了它們在市場中的作用。

在強大的基礎設施和對動物保健的高度關注的推動下，北美仍然是最大的動物藥品市場，到 2023 年價值將達到 140 億美元。監管框架、先進的研究設施和對獸藥的重大投資推動了該地區的成長。對伴侶動物和牲畜生產力提高解決方案的需求不斷增加，進一步擴大了區域市場的擴張。

2023年，美國動物藥品市場規模達127億美元。獸醫護理設施的不斷升級和對動物健康研究的投資進一步凸顯了美國市場的實力。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 寵物保險需求激增
      • 伴侶動物肥胖率上升
      • 加大政府對寵物照護的支持
      • 對網路獸藥局的需求不斷成長
    • 產業陷阱與挑戰
      • 與動物藥品相關的高成本
  • 成長潛力分析
  • 監管環境
  • 政策格局
  • 產品管道分析
  • 投資者概覽
  • 差距分析
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章：市場估計與預測：按產品分類，2018 年 - 2032 年

  • 主要趨勢
  • 藥品
    • 抗寄生蟲藥
    • 消炎劑
    • 抗感染藥
    • 其他藥品
  • 疫苗
    • 改良活疫苗 (MLV)
    • 去活化去活化疫苗
    • 其他疫苗
  • 藥用飼料添加劑
    • 抗生素
    • 維生素
    • 酵素
    • 抗氧化劑
    • 益生元和益生菌
    • 礦物質
    • 其他藥用添加劑

第 6 章：市場估計與預測：按動物類型，2018 - 2032

  • 主要趨勢
  • 畜牧動物
    • 家禽
    • 豬
    • 牛
    • 魚
    • 其他家畜動物
  • 伴侶動物
    • 狗
    • 貓
    • 馬匹
    • 其他伴侶動物

第 7 章：市場估計與預測：按管理途徑，2018 年 - 2032 年

  • 主要趨勢
  • 口服
  • 可注射
  • 專題
  • 其他給藥途徑

第 8 章：市場估計與預測：按配銷通路，2018 年 - 2032 年

  • 主要趨勢
  • 獸醫院
  • 獸醫診所
  • 藥局和藥局
  • 電子商務

第 9 章：市場估計與預測：按地區，2018-2032

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 波蘭
    • 荷蘭
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 台灣
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 海灣合作理事會國家
    • 以色列

第 10 章：公司簡介

  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Dechra Pharmaceuticals Ltd
  • Durvet, Inc.
  • Elanco Animal Health
  • Merck & Co., Inc
  • Neogen Corporation, Inc
  • Virbac SA
  • Vetoquinol SA
  • Zoetis, Inc
簡介目錄
Product Code: 4445

The global animal drugs market reached USD 37 billion in 2023 and is projected to grow at a CAGR of 5.4% between 2024 and 2032, surpassing USD 45 billion by the end of the forecast period. Key drivers include the rising prevalence of animal diseases, increased consumer awareness regarding animal health, and the growing adoption of livestock animals for food production. Advancements in veterinary pharmaceutical formulations also boost market growth, ensuring better efficacy and compliance.

Drugs, including anti-infectives, parasiticides, and vaccines, dominate the market, with continuous innovation fueling growth. In 2023, the drugs segment accumulated the largest share of 58.8% in the animal drugs market and is expected to grow significantly, aided by the introduction of novel formulations and increased use of combination therapies. Rising awareness about preventive care and the importance of vaccination programs for livestock and companion animals drive the demand for these drugs. Moreover, advancements in biotechnology and molecular research contribute to the development of highly effective treatments.

The livestock animal segment captured a dominant share of around 62.5% in 2023. Increased demand for high-quality meat, milk, and related products has amplified the need for effective healthcare solutions for cattle, poultry, and swine. Prophylactic and therapeutic drug use to prevent disease outbreaks and optimize animal productivity drive this segment's growth. Additionally, rising investments in farm animal health by producers and governments globally are expected to sustain robust demand.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$37 Billion
Forecast Value$59.6 Billion
CAGR5.4%

Injectable drugs amassed USD 16.6 billion in 2023 and are gaining traction as a preferred route of administration due to their quick efficacy and ease of dosage control. They are commonly used for vaccinations, antibiotics, and hormonal treatments in both companion animals and livestock. Innovations in formulation and delivery systems have improved the stability and effectiveness of injectable drugs, making them a vital tool in veterinary practice. This segment's growth is bolstered by increasing awareness and advancements in animal healthcare.

Veterinary hospitals held 37.4% of the overall market share in 2023 and are poised to remain the leading distribution channel, driven by the availability of comprehensive healthcare services and advanced treatments. A surge in pet ownership and increased focus on livestock welfare further support segment growth. The presence of skilled veterinarians and advanced diagnostic facilities in these hospitals ensures the effective administration of drugs. The trend toward integrated healthcare systems further strengthens their role in the market.

North America remains the largest market for animal drugs, valued at USD 14 billion in 2023, driven by robust infrastructure and a high focus on animal healthcare. Regulatory frameworks, advanced research facilities, and significant investments in veterinary medicine fuel growth in this region. Increasing demand for companion animals and livestock productivity enhancement solutions further amplifies the regional market's expansion.

The U.S. animal drugs market size reached USD 12.7 billion in 2023. Factors such as increased pet ownership, high livestock production, and regulatory support for disease control are fueling demand. Continuous upgrades in veterinary care facilities and investments in animal health research further underscore the U.S. market's strength.

Table of Contents

Chapter 1. Methodology & Scope

  • 1.1. Market scope & definitions
  • 1.2. Research design
    • 1.2.1. Research approach
    • 1.2.2. Data collection methods
  • 1.3. Base estimates & calculations
    • 1.3.1. Base year calculation
    • 1.3.2. Key trends for market estimation
  • 1.4. Forecast model
  • 1.5. Primary research and validation
    • 1.5.1. Primary sources
    • 1.5.2. Data mining sources

Chapter 2. Executive Summary

  • 2.1. Industry 360° synopsis

Chapter 3. Industry Insights

  • 3.1. Industry ecosystem analysis
  • 3.2. Industry impact forces
    • 3.2.1. Growth drivers
      • 3.2.1.1. Surging demand for pet insurance policies
      • 3.2.1.2. Rising rate of obesity in companion animals
      • 3.2.1.3. Increasing government support for pet care
      • 3.2.1.4. Growing demand for online veterinary pharmacies
    • 3.2.2. Industry pitfalls & challenges
      • 3.2.2.1. High cost associated with animal drugs
  • 3.3. Growth potential analysis
  • 3.4. Regulatory landscape
  • 3.5. Policy landscape
  • 3.6. Product pipeline analysis
  • 3.7. Investor overview
  • 3.8. Gap analysis
  • 3.9. Porter's analysis
  • 3.10.PESTEL analysis

Chapter 4. Competitive Landscape, 2023

  • 4.1. Introduction
  • 4.2. Company matrix analysis
  • 4.3. Competitive analysis of major market players
  • 4.4. Competitive positioning matrix
  • 4.5. Strategy dashboard

Chapter 5. Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

  • 5.1. Key trends
  • 5.2. Drugs
    • 5.2.1. Antiparasitic
    • 5.2.2. Anti-inflammatory
    • 5.2.3. Anti-infectives
    • 5.2.4. Other drugs
  • 5.3. Vaccines
    • 5.3.1. Modified Live Vaccines (MLV)
    • 5.3.2. Killed inactivated vaccines
    • 5.3.3. Other vaccines
  • 5.4. Medicated feed additives
    • 5.4.1. Antibiotics
    • 5.4.2. Vitamins
    • 5.4.3. Enzymes
    • 5.4.4. Antioxidants
    • 5.4.5. Prebiotics and probiotics
    • 5.4.6. Minerals
    • 5.4.7. Other medicated additives

Chapter 6. Market Estimates and Forecast, By Animal Type, 2018 - 2032 ($ Mn)

  • 6.1. Key trends
  • 6.2. Livestock animals
    • 6.2.1. Poultry
    • 6.2.2. Swine
    • 6.2.3. Cattle
    • 6.2.4. Fish
    • 6.2.5. Other livestock animals
  • 6.3. Companion animals
    • 6.3.1. Dogs
    • 6.3.2. Cats
    • 6.3.3. Horses
    • 6.3.4. Other companion animals

Chapter 7. Market Estimates and Forecast, By Route of Administration, 2018 - 2032 ($ Mn)

  • 7.1. Key trends
  • 7.2. Oral
  • 7.3. Injectable
  • 7.4. Topical
  • 7.5. Other routes of administration

Chapter 8. Market Estimates and Forecast, By Distribution Channel, 2018 - 2032 ($ Mn)

  • 8.1. Key trends
  • 8.2. Veterinary hospitals
  • 8.3. Veterinary clinics
  • 8.4. Pharmacy and drug stores
  • 8.5. e-commerce

Chapter 9. Market Estimates and Forecast, By Region, 2018- 2032 ($ Mn)

  • 9.1. Key trends
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. UK
    • 9.3.3. France
    • 9.3.4. Spain
    • 9.3.5. Italy
    • 9.3.6. Poland
    • 9.3.7. Netherlands
  • 9.4. Asia Pacific
    • 9.4.1. Japan
    • 9.4.2. China
    • 9.4.3. India
    • 9.4.4. Australia
    • 9.4.5. South Korea
    • 9.4.6. Taiwan
  • 9.5. Latin America
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Argentina
  • 9.6. Middle East and Africa
    • 9.6.1. South Africa
    • 9.6.2. GCC Countries
    • 9.6.3. Israel

Chapter 10. Company Profiles

  • 10.1. Boehringer Ingelheim International GmbH
  • 10.2.Ceva Sante Animale
  • 10.3.Dechra Pharmaceuticals Ltd
  • 10.4.Durvet, Inc.
  • 10.5.Elanco Animal Health
  • 10.6.Merck & Co., Inc
  • 10.7.Neogen Corporation, Inc
  • 10.8.Virbac S.A.
  • 10.9.Vetoquinol SA
  • 10.10. Zoetis, Inc